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論文の内容の要旨 
Abstract of thesis 
 
（目的 Purpose） 
The extracellular matrix (ECM) plays a critical role in the maintenance of the aortic wall and the 
fragmentation of elastic fibers is frequently associated with aortic diseases, including aortic aneurysms. 
The first part of the thesis is to directly address whether a decrease in quantity or quality of elastic fibers in vivo 
predispose the aorta to mechanical stress-induced remodeling and aneurysm formation using various mutant mice 
with the compromised elastic fibers. The second part of the thesis is to search the molecular markers of different 
subtypes of aortic aneurysms in humans, focusing on the ECM, signaling molecules, and smooth muscle cell markers. 
The author performed histological and molecular characterization of thoracic aortic aneurysm (TAA), including 
annuloaortic ectasia (AAE), ascending aortic aneurysm (aTAA) with and without bicuspid valve (BAV), and 
abdominal aortic aneurysm (AAA) from human patients. 
 
（対象と方法 Materials and Methods） 
 Eight-week-old male wild type (C57BL/6), heterozygous for an Eln-null allele (Eln+/-), heterozygous and 
homozygous for a Fbln5-null allele (Fbln5+/- and Fbln5-/-, respectively), and homozygous for a Thbs1-null allele 
(Thbs1-/-) were used to perform transverse aortic constriction (TAC) surgery to induce pressure overload in the 
 ascending aorta. After 5 weeks, ascending aorta were harvested for histological analysis. All protocol were approved 
by the Animal Experimentation Committee of University of Tsukuba. 
 The full-thickness specimens of human aneurysmal aortic tissues were collected in accordance with the 
research protocol approved by the Clinical Ethics Committee of University of Tsukuba Hospital (#27-217) with an 
informed consent paper from each patient for sample collection before operation. The 4-mm ascending aortic wall 
tissues were punched from patients undergoing coronary aortic bypass (CABG) surgery as control. Comparison 
among 5 groups, including AAE, aTAA with and without BAV, AAA and CABG, were performed by histology, 
Western blot and quantitative polymerase-chain reaction (qPCR) analysis. 
 
（結果 Results） 
 The maximal ascending aortic diameter in systole was significantly smaller in Eln+/- and Fbln5-/- mice 
compared to wild-type (WT) mice. TAC induced dilatation of the ascending aorta in Eln+/- and Fbln5-/- mice, 
comparably to that of WT mice, however, TAC did not induce aneurysm or dissection in the mutants. Thbs1 was 
clearly upregulated in the ascending aorta of Eln+/- mice after TA. In contrast, Thbs1-/- mice with normal elastic fiber 
structure showed decreased survival after TAC (38%) compared with WT mice (100%), and 50% of death was due 
to aortic rupture (3 ruptures). Necropsy and histological analyses found evidence of aortic diseases (3/7 aneurysms, 
2/7 dissection) with abnormal collagen deposition and elastic fiber fragmentation. Thb1 expression in TAA was 
significantly upregulated compared with control aortic samples. 
 Human aneurysm study revealed that the changes in the medial layers of AAA were consistent with 
atheroma, fragmentation and partial loss of elastic fibers, calcification b, intra-aortic wall hemorrhage, and collagen 
accumulation. Among TAA, aortic wall degradation was more severe in AAE than aTAA and the aortic root was 
more severe than the ascending aorta in Marfan syndrome (MFS) with fibrillin-1 (FBN1) mutations. 
 By qPCR analysis, TGFB1 and THBS1 were upregulated in aneurysm tissues and in the aortic wall of MFS. 
However, Western blots revealed that the THBS1 expression was significantly higher in AAA than TAA, and in 
aneurysmal lesions than non-aneurysmal lesions within the same TAA patients. 
 
（考察 Discussion） 
 Eln+/- and Fbln5-/- mice showed narrowing of the aortic lumen during development. However, TAC did not 
induce aneurysm, suggesting pressure overload alone was not sufficient to initiate aneurysm formation in these 
mutants. It was suggested that tension is not the only determinant of the aortic wall remodeling and that alteration of 
biomechanical signaling in vascular SMCs may be required for full development of aneurysms. 
Hbs1 is an adhesive glycoprotein that mediates cell-cell and cell-ECM interactions and Thbs1 is highly 
upregulated in the ascending aortas of TAC-treated wild-type mice. Thbs1-/- mice exhibited extracellular response of 
pressure overload and ascending aorta of Thbs1-/- mice exhibited loss of smooth muscle cells (SMCs), elastic fiber 
fragmentation, collagen accumulation and calcification. Since Thbs1 has recently been shown to contribute to the 
development of aortic aneurysms in mice, the author’s results indicate the opposite effect if Thbs1 in response to 
overload, which is protective against mechanical stress-induced maladaptative remodeling of the aorta. The lack of 
Thbs1 in vascular SMCs or fibroblasts may alter cell functions in response to the increased mechanical stress and 
induce maladaptive remodeling. It is possible that the presence of inflammation and fibroblast activation in TAC-
induced vascular remodeling may require Thbs1 to control these changes by acting on different cell types. 
The severe aortic wall degradation (in AAA and AAE) was associated with high inflammatory activity and 
elevated collagen accumulation, which may be related to the increased mechanical stress. It is of note that most 
aneurysm patients have hypertension for a long time. The medical treatments that target the mechanical stress reduce 
blood pressure, heart rate, and cardiac contractility. Angiotensin-converting enzyme inhibitor could limit 
inflammatory consequence and reduce proteolysis in the aortic wall, leading to decreased stiffness and greater 
collagen turnover. Angiotensin II receptor blockers also could inhibit the aortic wall remodeling process in response 
 to overload pressure in TAC mice model. 
TGF-ß pathway was upregulated in both TAA and AAA, especially in MFS and aTAA with BAV. Tbbs1 
was also elevated highest in AAA. By comparing the level of Thbs1 and TGF- ß1 among subtypes of aortic aneurysm 
and how they are related to the severity of aneurysms may help identifying the new therapeutic targets for human 
aortic aneurysms. 
The author concludes that Thbs1 contributes to aortic aneurysms pathology but Thbs1 is protective in the 
mechanical stress-induced aortic wall remodeling and that further analysis is required to elucidate the role of Thbs1 
as a potential therapeutic target for treating thoracic aortic aneurysms. 
  
 
 
審査の結果の要旨 
 Abstract of assessment result 
 
（批評 General Comments） 
The author found an involvement of Thbs1 in the remodeling process of ECM of aortas after mechanical stress. 
Although Thb1 may be one of the molecules involved in the development of aneurysms, the author could not produce 
an aneurysmal mouse model with mutations of Elastin or Fibulin5 The author could not identify the role of Thbs1 as 
positive, negative or dual, in the aneurysm formation. 
The findings of the heterogeneous upregulation of genes among the aneurysm samples from patients with 
aneurysms provide an important data, which are useful to treat patients with arterial diseases. 
 
（最終試験の結果 Assessment） 
The final examination committee conducted a meeting as a final examination on January 10, 2019. The applicant 
provided an overview of dissertation, addressed questions and comments raised during Q&A session. All of the 
committee members reached a final decision that the applicant has passed the final examination. 
 
（結論 Conclusion） 
The final examination committee approved that the applicant is qualified to be awarded Doctor of Philosophy in 
Medical Sciences. 
